Cited by 183RNA regulation and diseaseNeuroscience and Neuropharmacology ResearchRNA Research and Splicing

The DOI matches its Crossref record; 59 of the 61 references it cites were found in a registry or an index.

Editing for an AMPA receptor subunit RNA in prefrontal cortex and striatum in Alzheimer's disease, Huntington's disease and schizophrenia

Akbarian, Schahram, Smith, Martin A., Jones, Edward G.·1995·Brain Research

Open this paper in CoChat — free account

Abstract

Animal studies and cell culture experiments demonstrated that posttranscriptional editing of the transcript of the GluR-2 gene, resulting in substitution of an arginine for glutamine in the second transmembrane region (TM II) of the expressed protein, is associated with a reduction in Ca2+ permeability of the receptor channel. Thus, disturbances in GluR-2 RNA editing with alteration of intracellular Ca2+ homeostasis could lead to neuronal dysfunction and even neuronal degeneration. The present study determined the proportions of edited and unedited GluR-2 RNA in the prefrontal cortex of brains from patients with Alzheimer's disease, in the striatum of brains from patients with Huntington's disease, and in the same areas of brains from age-matched schizophrenics and controls, by using reverse transcriptase-polymerase chain reaction, restriction endonuclease digestion, gel electrophoresis and scintillation radiometry. In the prefrontal cortex of controls, 99.9% were edited; in the prefrontal cortex both of schizophrenics and of Alzheimer's patients approximately 1.0% of all GluR-2 RNA molecules were unedited and 99% were edited. In the striatum of controls and of schizophrenics, approximately 0.5% of GluR-2 RNA molecules were unedited and 99.5% were edited; in the striatum of Huntington's patients nearly 5.0% of GluR-2 RNA was unedited. In the prefrontal white matter of controls, approximately 7.0% of GluR-2 RNA was unedited. In the normal human prefrontal cortex and striatum,…

Integrity signals

Registry

Crossref · 10.1016/0006-8993(95)00922-d

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762
A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples.
Chomczyński, P. (1993) · PubMed · Cited by 2,788
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
RNA editing in brain controls a determinant of ion flow in glutamate-gated channels
Sommer, B., Köhler, M., Sprengel, R., & Seeburg, P. H. (1991) · Cell · doi:10.1016/0092-8674(91)90568-j · Cited by 1,517
A Family of AMPA-Selective Glutamate Receptors
Keinänen, K., Wisden, W., Sommer, B., Werner, P., Herb, A., Verdoorn, T. A., Sakmann, B., & Seeburg, P. H. (1990) · Science · doi:10.1126/science.2166337 · Cited by 1,479
Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit
Burnashev, N., Monyer, H., Seeburg, P. H., & Sakmann, B. (1992) · Neuron · doi:10.1016/0896-6273(92)90120-3 · Cited by 1,087
Cloning by functional expression of a member of the glutamate receptor family
Hollmann, M., O'Shea-Greenfield, A., Rogers, S. W., & Heinemann, S. F. (1989) · Nature · doi:10.1038/342643a0 · Cited by 1,016
Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.
Akbarian, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160008002 · Cited by 1,002
Self-citation

Show all 61 references

Research works printed but not linked: 1

Verity, 1992, Ca2+-dependent processes as mediators of neurotoxicity, Neurotoxicology, 13, 139

Sorted by citations

Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex
Mirnics, K., Middleton, F. A., Marquez, A., Lewis, D. A., & Levitt, P. (2000) · Neuron · doi:10.1016/s0896-6273(00)00085-4 · Cited by 882
Glutamatergic mechanisms in schizophrenia
Tsai, G., & Coyle, J. T. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082701.160735 · Cited by 577
RNA editing and death of motor neurons
Kawahara, Y., Ito, K., Sun, H. J., Aizawa, H., Kanazawa, I., & Kwak, S. (2004) · Nature · doi:10.1038/427801a · Cited by 536
The epigenetics of aging and neurodegeneration
Lardenoije, R., Iatrou, A., Kenis, G., Kompotis, K., Steinbusch, H. W. M., Mastroeni, D., Coleman, P., Lemere, C. A., Hof, P. R., van den Hove, D. L. A., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.002 · Cited by 381
Rodent models of prefrontal cortical function
Brown, V. J., & Bowman, E. M. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02164-1 · Cited by 321
Apoptotic mechanisms and the synaptic pathology of schizophrenia
Glantz, L. A., Gilmore, J. H., Lieberman, J. A., & Jarskog, L. F. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.08.014 · Cited by 293
Generation of neuronal variability and complexity
Muotri, A. R., & Gage, F. H. (2006) · Nature · doi:10.1038/nature04959 · Cited by 271
The many roles of an RNA editor
Keegan, L. P., Gallo, A., & O’Connell, M. A. (2001) · Nature Reviews Genetics · doi:10.1038/35098584 · Cited by 253
The AMPAR subunit GluR2: still front and center-stage11Published on the World Wide Web on 30 October 2000.
Tanaka, H., Grooms, S. Y., Bennett, M. V. L., & Zukin, R. S. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02951-6 · Cited by 247
Structural brain imaging in schizophrenia: a selective review
Pearlson, G. D., & Marsh, L. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00071-2 · Cited by 218
Apoptotic mechanisms in the pathophysiology of schizophrenia
Jarskog, L. F., Glantz, L. A., Gilmore, J. H., & Lieberman, J. A. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.03.010 · Cited by 219
Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis
Kwak, S., & Kawahara, Y. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0599-z · Cited by 215
The essential role of AMPA receptor GluR2 subunit RNA editing in the normal and diseased brain
Wright, A. L., & Vissel, B. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00034 · Cited by 229
The Molecular Pharmacology and Cell Biology of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptors
Palmer, C. L., Cotton, L., & Henley, J. M. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.7 · Cited by 211
Untitled work
(1999) · doi:10.1002/1531-8249(199912)46:6
Chemical anatomy of striatal interneurons in normal individuals and in patients with Huntington’s disease
Cicchetti, F., Prensa, L., Wu, Y., & Parent, A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00039-4 · Cited by 192
Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons
Hideyama, T., Yamashita, T., Aizawa, H., Tsuji, S., Kakita, A., Takahashi, H., & Kwak, S. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.033 · Cited by 189
Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity
Arendt, T. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.09.007 · Cited by 189
Calcium Permeable-AMPA Receptors and Excitotoxicity in Neurological Disorders
Guo, C., & Ma, Y. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.711564 · Cited by 198
ADAR Gene Family and A-to-I RNA Editing: Diverse Roles in Posttranscriptional Gene Regulation
Valente, L., & Nishikura, K. (2005) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(04)79006-6 · Cited by 168
RNA editing of the 5-HT2C receptor is reduced in schizophrenia
Sodhi, M., Burnet, P. W. J., MAKOFF, A. J., Kerwin, R., & Harrison, P. J. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000920 · Cited by 168
Induced Loss of ADAR2 Engenders Slow Death of Motor Neurons from Q/R Site-Unedited GluR2
Hideyama, T., Yamashita, T., Suzuki, T., Tsuji, S., Higuchi, M., Seeburg, P. H., Takahashi, R., Misawa, H., & Kwak, S. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2021-10.2010 · Cited by 158
Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia
Porter, R. H. P., Eastwood, S. L., & Harrison, P. J. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01404-7 · Cited by 158
Messenger RNA Editing of the Human Serotonin 5-HT2C Receptor
Fitzgerald, L. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00004-4 · Cited by 153
RNA editing in the forefront of epitranscriptomics and human health
Christofi, T., & Zaravinos, A. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2071-4 · Cited by 145
Pharmacology of AMPA/Kainate Receptor Ligands and Their Therapeutic Potential in Neurological and Psychiatric Disorders
Lees, G. J. (2000) · Drugs · doi:10.2165/00003495-200059010-00004 · Cited by 138
SRRM2, a Potential Blood Biomarker Revealing High Alternative Splicing in Parkinson's Disease
Shehadeh, L. A., Yu, K. M., Wang, L., Guevara, A., Singer, C., Vance, J. M., & Papapetropoulos, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009104 · Cited by 132
Nucleic acid aptamers targeting cell-surface proteins
Dua, P., Kim, S., & Lee, D.-K. (2011) · Methods · doi:10.1016/j.ymeth.2011.02.002 · Cited by 122
Hippocampus-specific deficiency in RNA editing of GluA2 in Alzheimer's disease
Gaisler‐Salomon, I., Kravitz, E., Feiler, Y., Safran, M., Biegon, A. R., Amariglio, N., & Rechavi, G. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.018 · Cited by 121
TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2
Aizawa, H., Sawada, J., Hideyama, T., Yamashita, T., Katayama, T., Hasebe, N., Kimura, T., Yahara, O., & Kwak, S. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0678-x · Cited by 119
Adenosine Deaminases Acting on RNA, RNA Editing, and Interferon Action
George, C. X., Gan, Z., Liu, Y., & Samuel, C. E. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0097 · Cited by 120
Lamina-specific abnormalities of AMPA receptor trafficking and signaling molecule transcripts in the prefrontal cortex in schizophrenia
Beneyto, M., & Meador‐Woodruff, J. H. (2006) · Synapse · doi:10.1002/syn.20329 · Cited by 113
ADAR1 and its implications in cancer development and treatment
Baker, A. R., & Slack, F. J. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.03.013 · Cited by 111
Structure and Sequence Determinants Required for the RNA Editing of ADAR2 Substrates
Dawson, T. R., Sansam, C. L., & Emeson, R. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310068200 · Cited by 108
Interferon Action and the Double‐Stranded RNA‐Dependent Enzymes ADAR1 Adenosine Deaminase and PKR Protein Kinase
Toth, A. M., Zhang, P., Das, S., George, C. X., & Samuel, C. E. (2006) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(06)81010-x · Cited by 101
GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: a reverse transcriptase-polymerase chain reaction (RT–PCR) study
Eastwood, S. L., Burnet, P. W. J., & Harrison, P. J. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00195-7 · Cited by 101
Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents
Ashe, P. C., Berry, M. D., & Boulton, A. A. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00159-2 · Cited by 100
RNA Editing at the Q/R Site for the Glutamate Receptor Subunits GLUR2, GLUR5, and GLUR6 in Hippocampus and Temporal Cortex from Epileptic Patients
Kortenbruck, G., Berger, E., Speckmann, E. ‐., & Mußhoff, U. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0394 · Cited by 97
Regulation of Editing and Expression of Glutamate α-Amino-Propionic-Acid (AMPA)/Kainate Receptors by Antidepressant Drugs
Barbon, A., Popoli, M., Via, L. L., Moraschi, S., Vallini, I., Tardito, D., Tiraboschi, E., Musazzi, L., Giambelli, R., Gennarelli, M., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.018 · Cited by 96
Deregulation of the A-to-I RNA editing mechanism in psychiatric disorders
Silberberg, G., Lundin, D., Navon, R., & Öhman, M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr461 · Cited by 93
Glutamate in schizophrenia: clinical and research implications
GOFF, D. C., & Wine, L. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00079-0 · Cited by 93
The Crystal Structure of the Zβ Domain of the RNA-editing Enzyme ADAR1 Reveals Distinct Conserved Surfaces Among Z-domains
Athanasiadis, A., Plácido, D., Maas, S., Brown, B. A., Lowenhaupt, K., & Rich, A. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.06.028 · Cited by 86
Aberrant RNA processing events in neurological disorders
Anthony, K., & Gallo, J. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.008 · Cited by 80
AMPA receptor-mediated neuronal death in sporadic ALS
Kwak, S., Hideyama, T., Yamashita, T., & Aizawa, H. (2010) · Neuropathology · doi:10.1111/j.1440-1789.2009.01090.x · Cited by 80
Defects in Pre-mRNA Processing as Causes of and Predisposition to Diseases
Stoilov, P., Meshorer, E., Gencheva, M., Glick, D., Soreq, H., & Stamm, S. (2002) · DNA and Cell Biology · doi:10.1089/104454902320908450 · Cited by 81
Abnormal N-linked glycosylation of cortical AMPA receptor subunits in schizophrenia
Tucholski, J., Simmons, M. S., Pinner, A. L., Haroutunian, V. H., McCullumsmith, R. E., & Meador‐Woodruff, J. H. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.01.031 · Cited by 77
Characterization of the AMPA‐Activated Receptors Present on Motoneurons
Greig, A., Donevan, S. D., Mujtaba, T., Parks, T. N., & Rao, M. S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740179.x · Cited by 77
Genome-wide analysis of differential RNA editing in epilepsyPreprint
Srivastava, P. K., Bagnati, M., Delahaye‐Duriez, A., Ko, J., Rotival, M., Langley, S. R., Shkura, K., Mazzuferi, M., Danis, B., van Eyll, J. M., et al. (2017) · Genome Research · doi:10.1101/gr.210740.116 · Cited by 79
Low editing efficiency of GluR2 mRNA is associated with a low relative abundance of ADAR2 mRNA in white matter of normal human brain
Kawahara, Y., Ito, K., Sun, H., Kanazawa, I., & Kwak, S. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02718.x · Cited by 73
Synaptic Dysfunction in Huntington’s Disease: Lessons from Genetic Animal Models
Cepeda, C., & Levine, M. S. (2020) · The Neuroscientist · doi:10.1177/1073858420972662 · Cited by 70
RNA rewriting, recoding, and rewiring in human disease
Zipeto, M., Jiang, Q., Melese, E. S., & Jamieson, C. H. M. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.07.001 · Cited by 70
A new mouse line with reduced GluA2 Q/R site RNA editing exhibits loss of dendritic spines, hippocampal CA1-neuron loss, learning and memory impairments and NMDA receptor-independent seizure vulnerability
Konen, L. M., Wright, A. L., Royle, G. A., Morris, G. P., Lau, B. K., Seow, P. W., Zinn, R., Milham, L. T., Vaughan, C. W., & Vissel, B. (2020) · Molecular Brain · doi:10.1186/s13041-020-0545-1 · Cited by 74
Sublethal Oxygen–Glucose Deprivation Alters Hippocampal Neuronal AMPA Receptor Expression and Vulnerability to Kainate-Induced Death
Ying, H. S.-C., Weishaupt, J. H., Grabb, M. C., Canzoniero, L. M. T., Sensi, S. L., Sheline, C. T., Monyer, H., & Choi, D. W. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-24-09536.1997 · Cited by 66
The Role of Oxidative Stress in the Dysregulation of Gene Expression and Protein Metabolism in Neurodegenerative Disease
Potashkin, J. A., & Meredith, G. E. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.144 · Cited by 64
Novel RNA Modifications in the Nervous System: Form and Function
Satterlee, J. S., Basanta‐Sanchez, M., Blanco, S., Li, J. B., Meyer, K. D., Pollock, J. D., Sadri‐Vakili, G., & Rybak‐Wolf, A. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3236-14.2014 · Cited by 63
Phenotypic Alterations in Hippocampal NPY- and PV-Expressing Interneurons in a Presymptomatic Transgenic Mouse Model of Alzheimer’s Disease
Mahar, I., Albuquerque, M. S., Mondragon-Rodriguez, S., Cavanagh, C., Davoli, M. A., Chabot, J.-G., Williams, S., Mechawar, N., Quirion, R., & Krantic, S. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00327 · Cited by 63
RNA metabolism in ALS: When normal processes become pathological
Droppelmann, C. A., Campos‐Melo, D., Ishtiaq, M., Volkening, K., & Strong, M. J. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.881377 · Cited by 63
Glutamate Receptor Incorporated in a Mixed Hybrid Bilayer Lipid Membrane Array, as a Sensing Element of a Biosensor Working under Flowing Conditions
Favero, G., Campanella, L., Cavallo, S., D’Annibale, A., Perrella, M., Mattei, E., & Ferri, T. (2005) · Journal of the American Chemical Society · doi:10.1021/ja042904g · Cited by 63
Contrasting molecular composition and channel properties of AMPA receptors on chick auditory and brainstem motor neurons
Ravindranathan, A., Donevan, S. D., Sugden, S. G., Greig, A., Rao, M. S., & Parks, T. N. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00667.x · Cited by 63
Differential regional distribution of AMPA receptor subunit messenger RNAs in the human spinal cord as visualized by in situ hybridization
Tomiyama, M., Rodríguez‐Puertas, R., Cortés, R., Christnacher, A., Sommer, B., Pazos, Á., Palacios, J. M., & Mengod, G. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00321-1 · Cited by 62
A role of ADAR2 and RNA editing of glutamate receptors in mood disorders and schizophrenia
Kubota‐Sakashita, M., Iwamoto, K., Bundo, M., & Kato, T. (2014) · Molecular Brain · doi:10.1186/1756-6606-7-5 · Cited by 60
RNA dysregulation in neurodegenerative diseases
Li, Y., & Sun, S. (2025) · The EMBO Journal · doi:10.1038/s44318-024-00352-6 · Cited by 65
Anatomical interrelationships of the medial preoptic area and other brain regions activated following male sexual behavior: A combined Fos and tract-tracing study
Coolen, L. M., Peters, H. J. P. W., & Veening, J. G. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980803)397:3 · Cited by 136
Self-citation
Excitotoxicity and ALS: What is unique about the AMPA receptors expressed on spinal motor neurons?
Kawahara, Y., & Kwak, S. (2005) · Amyotrophic Lateral Sclerosis · doi:10.1080/14660820510037872 · Cited by 58
Structure of Ionotropic Glutamate Receptors
Hollmann, M. (1999) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-08022-1_1 · Cited by 56
Glutamate receptor RNA editing in health and disease
Barbon, A., & Barlati, S. (2011) · Biochemistry (Moscow) · doi:10.1134/s0006297911080037 · Cited by 58
Neuroprotective Effects of Psychotropic Drugs in Huntington’s Disease
Lauterbach, E. C. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141122558 · Cited by 51
GluR2 AMPA Receptor Subunit Expression in Motoneurons at Low and High Risk for Degeneration in Amyotrophic Lateral Sclerosis
Laslo, P., Lipski, J., Nicholson, L. F. B., Miles, G. B., & Funk, G. D. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7653 · Cited by 53
Adenosine-to-inosine RNA editing in the immune system: friend or foe?
Nakahama, T., & Kawahara, Y. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03466-2 · Cited by 51
Expanding genome capacity via RNA editing
Gott, J. M. (2003) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2003.09.004 · Cited by 52
Distribution of AMPA receptor subunit mRNAs in the human basal ganglia: an in situ hybridization study
Tomiyama, M., Palacios, J. M., Cortés, R., Vilaró, M. T., & Mengod, G. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00022-3 · Cited by 50
RNA-binding proteins as molecular links between cancer and neurodegeneration
Campos‐Melo, D., Droppelmann, C. A., Volkening, K., & Strong, M. J. (2014) · Biogerontology · doi:10.1007/s10522-014-9531-2 · Cited by 51
Quantitative Analysis of Focused A-To-I RNA Editing Sites by Ultra-High-Throughput Sequencing in Psychiatric Disorders
Zhu, H., Urban, D. J., Blashka, J., McPheeters, M. T., Kroeze, W. K., Mieczkowski, P. A., Overholser, J. C., Jurjus, G., Dieter, L., Mahajan, G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043227 · Cited by 48
Human Bcl‐2 Protects Against AMPA Receptor‐Mediated Apoptosis
Cheung, N. S., Beart, P. M., Pascoe, C. J., John, C. A., & Bernard, O. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741613.x · Cited by 47
The Q/R editing site of AMPA receptor GluA2 subunit acts as an epigenetic switch regulating dendritic spines, neurodegeneration and cognitive deficits in Alzheimer’s disease
Wright, A. L., Konen, L. M., Mockett, B. G., Morris, G. P., Singh, A., Burbano, L. E., Milham, L. T., Hoang, M., Zinn, R., Chesworth, R., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00632-5 · Cited by 47
Dysregulated A to I RNA editing and non-coding RNAs in neurodegeneration
Singh, M. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2012.00326 · Cited by 44
Epitranscriptomic dynamics in brain development and disease
Shafik, A. M., Allen, E. G., & Jin, P. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01570-2 · Cited by 44
When Does ALS Start? ADAR2?GluA2 Hypothesis for the Etiology of Sporadic ALS
Hideyama, T., & Kwak, S. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00033 · Cited by 43
AMPA Receptors Are Involved in Store-Operated Calcium Entry and Interact with STIM Proteins in Rat Primary Cortical Neurons
Gruszczynska‐Biegala, J., Sladowska, M., & Kuźnicki, J. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00251 · Cited by 42
Minor Physical Anomalies in Older Patients With Late-Onset Schizophrenia, Early-Onset Schizophrenia, Depression, and Alzheimer's Disease
Lohr, J. B., Alder, M., Flynn, K., Harris, M. J., & McAdams, L. A. (1997) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199700540-00006 · Cited by 41
A Rapid New Assay to Detect RNA Editing Reveals Antipsychotic-Induced Changes in Serotonin-2C Transcripts
Sodhi, M., Airey, D. C., Lambert, W. E., Burnet, P. W. J., Harrison, P. J., & Sanders‐Bush, E. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014134 · Cited by 39
Significance of dysfunctional glutamatergic transmission for the development of psychotic symptoms.
Pietraszek, M. (2003) · PubMed · Cited by 39
A method to find tissue-specific novel sites of selective adenosine deamination
Ohlson, J. I. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni169 · Cited by 39
RNA editing (Q/R site) and flop/flip splicing of AMPA receptor transcripts in young and old brains
Carlson, N. G., Howard, J., Gahring, L. C., & Rogers, S. W. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00127-5 · Cited by 37
Schizophrenia and diabetes
Henderson, D. C., & Ettinger, E. R. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)51014-x · Cited by 36
The Good and the Bad of Glutamate Receptor RNA Editing
Filippini, A., Bonini, D., Via, L. L., & Barbon, A. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0201-z · Cited by 33
RNA Editing and Retrotransposons in Neurology
Krestel, H. E., & Meier, J. C. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00163 · Cited by 32
Dawn of Epitranscriptomic Medicine
Gatsiou, A., & Stellos, K. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.001927 · Cited by 31
Synapse-specific localization of NMDA and GABAA receptor subunits revealed by antigen-retrieval immunohistochemistry
Fritschy, J., Weinmann, O., Wenzel, A., & Benke, D. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980112)390:2 · Cited by 324
Self-citation
Expression of AMPA Receptor Flip and Flop mRNAs in the Nucleus Accumbens and Prefrontal Cortex after Neonatal Ventral Hippocampal Lesions
Stine, C. D. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00212-8 · Cited by 29
Interferons: potential roles in affect
E.C.Hurlock, I. V. (2001) · Medical Hypotheses · doi:10.1054/mehy.2000.1218 · Cited by 29
Synaptic scaling up in medium spiny neurons of aged BACHD mice: A slow-progression model of Huntington's disease
Rocher, A. B., Gubellini, P., Mérienne, N., Boussicault, L., Petit, F., Gipchtein, P., Jan, C., Hantraye, P., Brouillet, E., & Bonvento, G. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.10.016 · Cited by 29
Molecular analysis of AMPA-specific receptors: subunit composition, editing, and calcium influx determination in small amounts of tissue
Lee, J. C., Greig, A., Ravindranathan, A., Parks, T. N., & Rao, M. S. R. (1998) · Brain Research Protocols · doi:10.1016/s1385-299x(98)00035-x · Cited by 28
Immunohistochemical study of the hnRNP A2 and B1 in the hippocampal formations of brains with Alzheimer's disease
Mizukami, K., Ishikawa, M., Iwakiri, M., Ikonomovic, M. D., DeKosky, S. T., Kamma, H., & Asada, T. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.05.070 · Cited by 27
RNA Editing in Neurological and Neurodegenerative Disorders
Cruz, P. H. C., & Kawahara, Y. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0787-9_18 · Cited by 27
Activity Dependent Inhibition of AMPA Receptors by Zn 2+
Carrillo, E. C., Bhatia, N. K., Akimzhanov, A. M., & Jayaraman, V. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1481-20.2020 · Cited by 26
ADAR2 enzymes: efficient site-specific RNA editors with gene therapy aspirations
Hajji, K., Sedmík, J., Cherian, A., Amoruso, D., Keegan, L. P., & O’Connell, M. A. (2022) · RNA · doi:10.1261/rna.079266.122 · Cited by 26
RNA Editing: A New Therapeutic Target in Amyotrophic Lateral Sclerosis and Other Neurological Diseases
Hosaka, T., Tsuji, H., & Kwak, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010958 · Cited by 26
The Association between Long-Term DDT or DDE Exposures and an Altered Sperm Epigenome—a Cross-Sectional Study of Greenlandic Inuit and South African VhaVenda Men
Lismer, A., Shao, X., Dumargne, M.-C., Lafleur, C., Lambrot, R., Chan, D., Toft, G. V., Bonde, J. P., MacFarlane, A. J., Bornman, R., et al. (2024) · Environmental Health Perspectives · doi:10.1289/ehp12013 · Cited by 28
Inosine and its methyl derivatives: Occurrence, biogenesis, and function in RNA
Dutta, N., Deb, I., Sarzyńska, J., & Lahiri, A. (2022) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2022.01.001 · Cited by 23

Authors: Akbarian, S., Smith, M. A., & Jones, E. G.
Affiliations: University of California, Irvine (US)
Corresponding author: Jones, Edward G.
ORCID: Akbarian, Schahram
Jones, Edward G.
Venue: Brain Research
Publisher: Elsevier BV
Published: 1995-11
Volume: 699
Issue: 2
Pages: 297-304
ISSN: 0006-8993 (ISSN-L)
DOI: 10.1016/0006-8993(95)00922-d
OpenAlex: W2073364812
Cited by: 183
References: 61
Citations by year: 2026: 1 · 2025: 5 · 2024: 8 · 2023: 9 · 2022: 10 · 2021: 4 · 2020: 5 · 2019: 1 · 2018: 4 · 2017: 4 · 2016: 5 · 2015: 8 · 2014: 7 · 2013: 8 · 2012: 3
FWCI: 1.61
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Brain Research (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5p50mh044188-05)
U.S. Public Health Service
University of California, Irvine
National Institute of Mental Health (MH44188)
National Institute on Drug Abuse
National Institute of Neurological Disorders and Stroke (R01NS033213, NS-33213, NS21377, R01NS021377)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Keywords: AMPA receptors, prefrontal cortex, striatum, Alzheimer's disease, Huntington's disease, schizophrenia, calcium permeability, neuronal dysfunction, neurodegeneration
MeSH terms: Aged, Alzheimer Disease, Autoradiography, Corpus Striatum, Humans, Huntington Disease, Middle Aged, Nerve Degeneration, RNA, Schizophrenia, Prefrontal Cortex, Receptors, AMPA

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Editing for an AMPA receptor subunit RNA in prefrontal cortex and striatum in Alzheimer's disease, Huntington's disease and schizophrenia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks